

Trevi Therapeutics, Inc. Email Formats
Contact top employees from
Trevi Therapeutics, Inc.
- Trevi Therapeutics, Inc. uses 6 different email formats. The most common is firstNamelastName (for example, janedoe@trevitherapeutics.com), which appears in about 57% of work addresses.
- Other common patterns include:
- lastNamefirstNameInitial: doej@trevitherapeutics.com (4%)
- lastName.firstNameInitial: doe.j@trevitherapeutics.com (35%)
Trevi Therapeutics, Inc.’s Popular Email Formats
| Format | Example | Percentage |
|---|---|---|
Format firstNamelastName | Percentage: 57% | |
Format lastName.firstNameInitial | Percentage: 35% | |
Format lastNamefirstNameInitial | Percentage: 4% | |
Format lastName-firstNameInitial | Percentage: 2% | |
Format lastNameInitial_firstNameInitial | Percentage: 1% | |
Format lastName_firstNameInitial | Percentage: 1% |
Contact top employees from
Trevi Therapeutics, Inc.
Farrell SimonChief Commercial Officer (CCO)
Alexis GalloSenior Manager, R&D Finance
Katherine TakakiVice President, Global Regulatory Affairs
David HastingsChief Financial Officer
Margaret FoleyVice President
Colleen HamiltonVice President, Clinical Development Operations
Jim CassellaChief Development Officer (CDO)
Anne VanLentMember Board Of Directors. Audit Committee Chair
Dana Fox McInerneyVice President, Medical Affairs & Scientific Communications
Rebecca DrainVice President, Global Regulatory Affairs
Ryan TorpeySr. Manager, Site Budgets and Contracts
Madelyn GoodSr. Manager, Clinical Development Operations
Sherry MinorClinical Trial Manager
Paula BuckleyVice President Clinical Operations
Lara LewkowiczAccounting Manager
Jonathan CarlsonAssociate Director, FP&A and Accounting Operations
0% completed
Verify Trevi Therapeutics, Inc. Business Emails
Trevi Therapeutics, Inc. employee email verification for instant deliverability checks.Companies Similar to Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. Corporate Information: FAQ
Trevi Therapeutics, Inc., founded in 2011, operates as an independent biotech company based in New Haven, Connecticut within the Greater Hartford market. With a workforce of 10 to 50 employees, it generates annual revenue between $1 and $10 million and falls under SIC code 2834.
The executive team is led by President and CEO Jennifer Good, with Vice Presidents Katherine Takaki, Margaret Foley, Colleen Hamilton, Dana Fox McInerney, Rebecca Drain, Paula Buckley, and Farrell Simon heading Global Regulatory Affairs, Medical Affairs & Scientific Communications, Clinical Development Operations, Quality Assurance and Compliance, and Commercial operations respectively. Senior roles include Sally Lam as Senior Director of QA & Compliance, Olivia Cross coordinating Marketing & Communications, and Sherry Minor directing Clinical Operations.
The executive team is led by President and CEO Jennifer Good, with Vice Presidents Katherine Takaki, Margaret Foley, Colleen Hamilton, Dana Fox McInerney, Rebecca Drain, Paula Buckley, and Farrell Simon heading Global Regulatory Affairs, Medical Affairs & Scientific Communications, Clinical Development Operations, Quality Assurance and Compliance, and Commercial operations respectively. Senior roles include Sally Lam as Senior Director of QA & Compliance, Olivia Cross coordinating Marketing & Communications, and Sherry Minor directing Clinical Operations.
Trevi Therapeutics, Inc. uses 6 email formats across its organization. The most common pattern is firstNamelastName (e.g., janedoe@trevitherapeutics.com), used in approximately 57% of work addresses.
Trevi Therapeutics, Inc. currently employs over 10-50 people from United States, with a head office in New Haven, CT.
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.





